Brianna Mullins
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$5.3MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $5.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 27, 2024 | NIH | SBIR Phase I 3STEP: A swab-seal-read, point-of-care nucleic acid test to address disparity in STI screening and prevention | $276K | SALUS DISCOVERY LLC |
| Dec 12, 2023 | NIH | SBIR Phase II Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $819K | SALUS DISCOVERY LLC |
| Apr 1, 2023 | NIH | SBIR Phase I Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology | $276K | SALUS DISCOVERY LLC |
| Mar 24, 2023 | NIH | SBIR Phase I Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology | $276K | SALUS DISCOVERY LLC |
| May 10, 2022 | NIH | SBIR Phase II Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $963K | SALUS DISCOVERY LLC |
| May 10, 2022 | NIH | SBIR Phase II Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $963K | SALUS DISCOVERY LLC |
| Jan 24, 2020 | NIH | SBIR Phase II Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $436K | SALUS DISCOVERY LLC |
| Aug 27, 2018 | NIH | SBIR Phase I Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression | $350K | SALUS DISCOVERY LLC |
| Aug 24, 2018 | NIH | SBIR Phase II Getting More from Less: Multi-omic Capture and Analysis from Patient Samples | $534K | SALUS DISCOVERY LLC |
| Mar 1, 2018 | NIH | SBIR Phase I Development of a cell based assay to assess antigen specific tolerance | $225K | SALUS DISCOVERY LLC |
| Feb 15, 2018 | NIH | SBIR Phase I Development of a cell based assay to assess antigen specific tolerance | $225K | SALUS DISCOVERY LLC |
Peer ranks
Federal funding#256
Awards as PI#114
Patents#505
Companies
- SALUS DISCOVERY LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.